|
NARS expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.480000E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.509800E-01 |
| Normal-vs-Stage2 |
9.549600E-01 |
| Normal-vs-Stage3 |
2.332400E-01 |
| Normal-vs-Stage4 |
5.330600E-01 |
| Stage1-vs-Stage2 |
5.347000E-01 |
| Stage1-vs-Stage3 |
8.676400E-01 |
| Stage1-vs-Stage4 |
8.532800E-01 |
| Stage2-vs-Stage3 |
4.097400E-01 |
| Stage2-vs-Stage4 |
6.707400E-01 |
| Stage3-vs-Stage4 |
7.849600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.117700E-02 |
| Normal-vs-AfricanAmerican |
7.713400E-01 |
| Normal-vs-Asian |
1.907360E-01 |
| Caucasian-vs-AfricanAmerican |
2.977600E-01 |
| Caucasian-vs-Asian |
4.256400E-01 |
| AfricanAmerican-vs-Asian |
2.574400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.476000E-02 |
| Normal-vs-Female |
8.630800E-01 |
| Male-vs-Female |
1.269020E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
8.369800E-01 |
| Normal-vs-Extreme_Weight |
1.436650E-03 |
| Normal-vs-Obese |
4.788000E-01 |
| Normal-vs-Extreme_Obese |
4.463400E-01 |
| Normal_Weight-vs-Extreme_Weight |
5.985900E-02 |
| Normal_Weight-vs-Obese |
6.713400E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.092200E-01 |
| Extreme_Weight-vs-Obese |
2.192600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
1.368430E-01 |
| Obese-vs-Extreme_Obese |
2.888600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.867810E-01 |
| Normal-vs-Age(41-60Yrs) |
1.190020E-01 |
| Normal-vs-Age(61-80Yrs) |
1.674960E-01 |
| Normal-vs-Age(81-100Yrs) |
5.161400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.003000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.587400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.198200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.061000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.904200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.722000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.397200E-03 |
| Normal-VS-Type2 PRCC |
6.108200E-01 |
| Normal-VS-KIRP CIMP |
7.170200E-01 |
| Normal-VS-Unclassified PRCC |
2.258800E-01 |
| Type1 PRCC-VS-Type2 PRCC |
4.231800E-02 |
| Type1 PRCC-VS-KIRP CIMP |
3.309200E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
4.454600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
5.471000E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
2.069600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
6.426400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.756400E-02 |
| Normal-vs-N1 |
3.916100E-02 |
| Normal-vs-N2 |
3.780600E-01 |
| N0-vs-N1 |
5.772400E-01 |
| N0-vs-N2 |
5.851400E-01 |
| N1-vs-N2 |
7.442600E-01 |
|
|
